Streetbeat News

Earnings

OKYO

OKYO Pharma Limited (NASDAQ:OKYO) announced positive results from a Phase 2 trial of OK-101 for dry eye disease, showing significant improvements in ocular pain, Tear Film Break-Up Time, and other symptoms. The results support moving to Phase 3 development. Despite these positive findings, OKYO shares dropped 10.01% to $1.58.

Portfolio Pulse from Vandana Singh

March 22, 2024 | 3:53 pm

CUTR

Cutera, Inc. (NASDAQ:CUTR) shares plummeted after reporting Q4 results with a wider loss per share of $(1.36) compared to analyst estimates of a loss of 94 cents. Despite beating revenue expectations with $49.5 million, the company saw a significant decline in capital equipment systems and recurring revenue sources. Non-GAAP gross profit and margin drastically decreased, affected by a non-cash expense for excess and obsolete inventory. The company forecasts 2024 annual revenue between $160 million to $170 million, slightly below the estimate of $168.26 million. CUTR shares dropped 28.2% to $1.65.

Portfolio Pulse from Nabaparna Bhattacharya

March 22, 2024 | 3:50 pm

NKE

Nike Inc (NYSE:NKE) reported Q3 results that exceeded expectations but announced a low single-digit revenue decline for the first half of fiscal 2025, leading to a bearish outlook. The stock has been underperforming, down 26% over the past year and 14.3% year-to-date. Technical indicators such as MACD, RSI, and Bollinger Bands signal a strong downward trend and selling pressure. Despite surpassing Q3 expectations, the revised revenue projections have negatively impacted investor sentiment.

Portfolio Pulse from Surbhi Jain

March 22, 2024 | 3:48 pm

DERM

Journey Medical's shares are trading lower following the announcement of their Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 3:39 pm

BAC

BSX

LRCX

UBER

XOM

Benzinga's Stock Whisper Index highlights five stocks: Uber Technologies, Boston Scientific Corporation, Exxon Mobil Corporation, Lam Research Corporation, and Bank of America Corporation. These stocks are gaining investor attention due to various factors such as Uber's expansion in Europe, Boston Scientific's FDA approvals, Exxon's strategic petroleum reserve acquisition, Lam Research's supply chain diversification, and Bank of America's potential gains from regional bank pressures. Each company is experiencing positive developments that could influence their stock prices in the short term.

Portfolio Pulse from Chris Katje

March 22, 2024 | 3:27 pm

LULU

Lululemon Athletica Inc. (NASDAQ:LULU) shares dropped after the company reported Q4 earnings that beat estimates but provided weaker than expected guidance for Q1 due to lower consumer demand. Analysts have subsequently lowered their price targets on LULU stock.

Portfolio Pulse from Erica Kollmann

March 22, 2024 | 3:23 pm

CUTR

Cutera's shares dropped following the announcement of their Q4 adjusted EPS results, which fell short of expectations.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 3:14 pm

BIOL

VXF

BIOLASE, Inc. (NASDAQ:BIOL) shares surged after reporting a smaller-than-expected Q4 FY23 EPS loss. Despite revenue slightly missing estimates, the company's outlook for FY24 is positive, with expected net revenue growth and positive adjusted EBITDA. BIOLASE's growth is attributed to increased adoption of its dental lasers and consumables. Investors can also gain exposure to BIOLASE through the Vanguard Extended Market ETF (NYSE:VXF).

Portfolio Pulse from Lekha Gupta

March 22, 2024 | 3:13 pm

IDN

Intellicheck's stock price increased following the announcement of improved year-over-year earnings per share (EPS) for Q4.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 3:10 pm

CRGX

CARGO Therapeutics shares are trading higher following the announcement of their Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 2:59 pm